MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹11,907 Cr | ₹9,919 Cr | ₹8,012 Cr | ₹6,735 Cr | ₹5,304 Cr |
What is the latest Profit & Loss Account Balance ratio of MANKIND PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹11,907 Cr |
| Mar2024 | ₹9,919 Cr |
| Mar2023 | ₹8,012 Cr |
| Mar2022 | ₹6,735 Cr |
| Mar2021 | ₹5,304 Cr |
How is Profit & Loss Account Balance of MANKIND PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹11,907 Cr | 20.05 | |
| Mar2024 | ₹9,919 Cr | 23.80 | |
| Mar2023 | ₹8,012 Cr | 18.96 | |
| Mar2022 | ₹6,735 Cr | 26.99 | |
| Mar2021 | ₹5,304 Cr | - | |
Compare Profit & Loss Account Balance of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹94,905.1 Cr | -5% | 2.3% | -5.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,469.0 Cr | -2.8% | -1% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,305.0 Cr | -3.3% | 0.4% | -2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,014.0 Cr | -3.1% | 2.9% | 36.9% | Stock Analytics | |
| CIPLA | ₹111,388.0 Cr | -2.7% | 5.3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,381.0 Cr | -4.1% | -3.7% | 3.7% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -5% |
2.3% |
-5.4% |
| SENSEX | -2.4% |
-3.7% |
-9.2% |
You may also like the below Video Courses